Old Web
English
Sign In
Acemap
>
authorDetail
>
Mandana Taghizadeh Manzari
Mandana Taghizadeh Manzari
Memorial Sloan Kettering Cancer Center
Medicine
Lymphoma
Venetoclax
Cancer
Pharmacology
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tumor Targeted Nanoparticles Improve Therapeutic Index of BCL2 and MCL1 dual inhibition.
2020
Blood
Neeta Bala Tannan
Mandana Taghizadeh Manzari
Laurie Herviou
Mariana Da Silva Ferreira
Connor J Hagen
Hiroto Kiguchi
Katia Manova-Todorova
Venkatraman E. Seshan
Elisa de Stanchina
Daniel A. Heller
Anas Younes
Show All
Source
Cite
Save
Citations (3)
Dual Inhibition of MCL1 and BCL2 in Lymphoma Using Tumor Targeted Nanoparticles
2019
Blood
Neeta Bala Bala
Mandana Taghizadeh Manzari
Mariana Da Silva Ferreira
Zahra Asgari
Connor Hagen
Venkatraman E. Seshan
Elisa de Stanchina
Katia Manova-Todorova
Daniel A. Heller
Anas Younes
Show All
Source
Cite
Save
Citations (1)
SCIDOT-41. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
2019
Neuro-oncology
Hiroto Kiguchi
Mandana Taghizadeh Manzari
Jake Vaynshteyn
Jeffrey Gerwin
Daniel Tylawsky
Na Li
Janki Shah
Yosi Shamay
Matthew B. Greenblatt
Daniel A. Heller
G. Praveen Raju
Show All
Source
Cite
Save
Citations (0)
1